Medical Cannabis 2024 Update: Medical Cannabis Research & PM&R Practice-Session Recording

Video Transcription

Video Summary

The session was led by Dr. Mitch Priwas, covering updates on medical cannabis research and practice in physical medicine and rehabilitation (PM&R). The focus was on the educational aspect, encouraging participants to engage with evaluation forms to refine future programming. Dr. Priwas noted the unique contribution of PM&R in educating about medical cannabis, given its unique medical subspecialty stance on this subject.<br /><br />Dr. Michelle Sexton presented insights from her work at UCSD, where she led one of the first cannabis clinics at an academic setting, originally initiated during the opioid epidemic to help patients manage pain with cannabis as an alternative. Her research indicated that cannabis, specifically THC, can be effective for neuropathic pain, particularly when vaporized. However, higher THC concentrations may be counterproductive, highlighting the importance of dosage awareness.<br /><br />Dr. Michael Solino discussed the role of medical cannabis in managing spasticity, pointing out the limited direct evidence despite patient interest. Notably, Sumitex, a THC and CBD oral spray, is approved outside the U.S. but faced challenges with FDA approval due to inconsistencies in efficacy based on traditional clinical measures.<br /><br />Dr. Ari Grice shared practical approaches to utilizing cannabis in orthopedic settings, underlining the need for healthcare professional guidance to ensure responsible use, particularly focusing on controlling THC dosages to prevent intoxication.<br /><br />Dr. Stuart Glassman’s presentation addressed the complexity of evolving cannabis regulations, noting the importance of understanding state and federal laws, especially concerning veteran care. Upcoming legislation might influence these dynamics, with organizations like the AMA adapting to changes as medical and recreational cannabis laws evolve.<br /><br />The discussion concluded with a focus on the implications of potential federal scheduling changes and the importance of better structuring cannabis-related medical advice and education within healthcare systems to optimize patient outcomes.

Keywords

medical cannabis

physical medicine

rehabilitation

THC

neuropathic pain

spasticity

dosage awareness

cannabis regulations

veteran care

federal laws

patient outcomes

Sumitex

cannabis education